Double-blind, Placebo-controlled, Escalating Single-dose, Phase 2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of THR-18 in Subjects With Acute Ischemic Stroke and Treated With tPA

Trial Profile

Double-blind, Placebo-controlled, Escalating Single-dose, Phase 2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of THR-18 in Subjects With Acute Ischemic Stroke and Treated With tPA

Completed
Phase of Trial: Phase II

Latest Information Update: 14 May 2015

At a glance

  • Drugs THR 18 (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Sponsors D-Pharm
  • Most Recent Events

    • 14 May 2015 Final results published in D-Pharm media release.
    • 03 Feb 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 13 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top